Recent Posts
- Ukraine recovery should be based on development of territorial communities, innovations, involvement of professional domestic community – results of ESUR forum 29.06.2023
- Ukraine repatriates five more seriously wounded Russian POWs 10.04.2023
- Rada intends to include history of Ukraine, foreign language in final certification for general secondary education 10.04.2023
- Rada terminates protocol on joint anti-terrorist measures in CIS territories for Ukraine 10.04.2023
- 100 Ukrainians, incl defenders of Mariupol, returned according to swap procedure – Yermak 10.04.2023
Imports of drugs to Ukraine 38% down in 2022, exports of Ukrainian drugs 24% down – study
KYIV. March 29 (Interfax-Ukraine) – Imports of medicines to Ukraine in 2022, after a five-year growth, decreased by 38% compared to the previous year, to $1.9 billion from $3.1 billion.
It is evidenced by the data of a study conducted by the Top Lead marketing agency jointly with the Darnitsa pharmaceutical company.
According to the study, the largest importers of medicines to Ukraine are Germany, with an import volume of about $368 million, India ($173 million), France ($31 million), Italy ($125 million), and Slovenia ($110 million).
At the same time, the export of Ukrainian medicines in 2022 fell by 24% compared to 2021 and reached $238 million.
The largest buyer of Ukrainian medicines is Uzbekistan, where Ukrainian enterprises exported products worth almost $52 million, and it was 36% less than a year earlier.
At the same time, other countries included in the top three buyers of Ukrainian medicines increased exports: Kazakhstan by 12% (to $32 million) and Lithuania by 324% (to $23 million).
“In 2022, Ukrainian companies stopped selling medicines to Russia and Belarus, and exports to Lithuania and Latvia increased. But, despite this, most Ukrainian pharmaceutical exports go to Asia,” the report authors said.
They also said that although the largest drug manufacturers in Ukraine have GMP certificates issued by the State Service of Ukraine on Medicines and Drugs Control, confirming the production and control of drugs in line with international quality standards, the EU does not yet recognize these certificates. “Therefore, for export to the EU, the manufacturer shall undergo additional verification by the regulatory authorities of a particular EU country. The task of Ukraine is to achieve recognition of Ukrainian certificates in the EU soon,” the study authors said.
